Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-07 Sale | 2022-12-09 4:07 pm | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 16,860 | $36.93 | $622,611 | 50,497 (Direct) | View |
2020-06-09 Purchase | 2020-06-10 07:54 am | Celldex Therapeutics Inc. | CLDX | KELER TIBOR Executive VP & CSO | 5,000 | $2.9908 | $14,954 | 7,357 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-17 4:13 pm | 2025-06-13 2034-06-13 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 93,000 | $0 | 93,000 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 4:14 pm | 2024-06-15 2033-06-15 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 92,000 | $0 | 92,000 (Direct) | View |
2022-12-07 Exercise | 2022-12-09 4:07 pm | N/A 2029-06-19 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 16,860 | $0 | 50,497 (Direct) | View |
2022-12-07 Exercise | 2022-12-09 4:07 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 16,860 | $2.78 | 50,497 (Direct) | View |
2022-06-16 Option Award | 2022-06-17 4:11 pm | 2023-06-16 2032-06-16 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR EXECUTIVE VP & CSO | 91,000 | $0 | 91,000 (Direct) | View |
2021-06-17 Option Award | 2021-06-21 4:26 pm | 2022-06-17 2031-06-17 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR Executive VP & CSO | 91,000 | $0 | 91,000 (Direct) | View |
2020-06-18 Option Award | 2020-06-19 08:05 am | 2021-06-18 2030-06-18 | Celldex Therapeutics Inc. | CLDX | KELER TIBOR Executive VP & CSO | 108,000 | $0 | 108,000 (Direct) | View |